SCHEMBL7709369

SCHEMBL7709369

COc1ccc(C2CC(=O)N(Cc3cccc(C(F)(F)F)c3F)C2)c2c1oc1ccccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.66
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
PDE4A P27815 3/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
ALDH1A1 P00352 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
MAOA P21397 1/20 0.36
P2RX7 Q99572 4/20 0.35
TP53 P04637 1/20 0.35
C5AR1 P21730 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708488 0.82 PDE10A (0.78) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL8271479 0.81 PDE10A (0.66) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL7703623 0.81 PDE10A (0.84) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL8272028 0.80 PDE10A (0.75) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL8272706 0.80 PDE10A (0.67) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL7711236 0.80 PDE10A (0.87) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL8271482 0.80 PDE10A (0.71) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL7709755 0.79 PDE10A (0.73) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL8271910 0.79 PDE10A (0.73) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2
SCHEMBL8271478 0.79 PDE10A (0.63) PDE10ACYP17A1CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed